Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Leptin-based immune intervention: current status and future directions.

Antonio La Cava1, Giuseppe Matarese, Fanny M Ebling

  • 1Department of Medicine, University of California Los Angeles, 1000 Veteran Avenue 32-59, Los Angeles, CA 90095-1670, USA. alacava@mednet.ucla.edu

Current Opinion in Investigational Drugs (London, England : 2000)
|February 5, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The immunoregulatory role of progesterone during embryo implantation and pregnancy.

Trends in endocrinology and metabolism: TEM·2026
Same author

Physical exercise modulates T cell activity and mitigates synaptic dysfunction in multiple sclerosis through vagus nerve engagement.

Brain, behavior, and immunity·2026
Same author

Immunophenotypic skewing of B cells toward IgD⁻CD27⁻IgG⁺ subtype and metabolic attenuation in colorectal cancer.

Scientific reports·2026
Same author

Effect of dynamics and timing of SARS-CoV-2 vaccination on immune response in people with multiple sclerosis during cladribine treatment.

Clinical immunology (Orlando, Fla.)·2026
Same author

Multiple sclerosis-associated EBNA2 variants influence the response to peginterferon beta-1a therapy.

Journal of autoimmunity·2026
Same author

Treg Susceptibility to Cladribine-Induced Depletion Correlates With Therapy Response in Patients With Multiple Sclerosis.

Neurology(R) neuroimmunology & neuroinflammation·2025

Leptin, a hormone, influences immune responses and may offer new treatments for autoimmune diseases. Leptin antagonists are being studied in preclinical models to combat chronic inflammation.

Area of Science:

  • Immunology
  • Endocrinology
  • Autoimmunity

Background:

  • Leptin's role extends beyond obesity to immune system regulation.
  • Leptin connects nutritional status and energy balance to T-helper 1 immune responses.
  • Pro-inflammatory T-helper 1 responses are implicated in chronic inflammation and autoimmunity.

Purpose of the Study:

  • To review preclinical evidence on leptin's immune functions.
  • To explore leptin-based therapies for chronic inflammatory and autoimmune conditions.
  • To assess the potential of leptin antagonists in managing autoimmunity.

Main Methods:

  • Review of current preclinical studies.
  • Analysis of leptin's role in immune regulation.
  • Evaluation of leptin antagonist interventions in animal models.

Related Experiment Videos

Main Results:

  • Leptin modulates T-helper 1 immune responses.
  • Leptin antagonists show promise in suppressing inflammation and autoimmunity in rodents.
  • Preclinical data support leptin-based strategies for immune modulation.

Conclusions:

  • Leptin is a key regulator linking metabolism to immunity.
  • Targeted leptin intervention strategies warrant further investigation for autoimmune diseases.
  • Leptin-based approaches offer potential therapeutic avenues for chronic inflammation.